Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Adastra Hldgs Inc (CSE: XTRX )

0.0950 UNCHANGED
Official Closing Price Updated: 3:47 PM EDT, Aug 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0950
Bid (Size) 0.0750 (11,000)
Ask (Size) 0.1050 (500)
Prev. Close 0.0950
Today's Range 0.0950 - 0.0950
52wk Range 0.0900 - 0.3350
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Adastra Announces Intention to Terminate SEC Reporting Obligations
Via ACCESSWIRE
Canadian Cannabis Concentrates Producer, Adastra, Reports Third Year Of Record Revenue, But Also Higher Losses
Via Benzinga
Topics Cannabis
Exposures Cannabis

Performance

YTD
-56.82%
-56.82%
1 Month
-5.00%
-5.00%
3 Month
-52.50%
-52.50%
6 Month
-59.57%
-59.57%
1 Year
-69.84%
-69.84%

More News

Read More
ADASTRA HOLDINGS REPORTS FY2023 RESULTS; MARKING THIRD CONSECUTIVE YEAROF RECORD REVENUE
Via ACCESSWIRE
Adastra Holdings Announces Lachlan McLeod as Interim CEO
Via ACCESSWIRE
Adastra Holdings Announces New Director
Via ACCESSWIRE
Adastra Holdings Receives Dual Nominations at 2023 Growup Awards and Gala
Via ACCESSWIRE
Adastra Holdings Reports Second Quarter Results; Demonstrating Record Quarterly Revenue of $10.9m
Via ACCESSWIRE
Adastra to Defend Lawsuit
Via ACCESSWIRE
Adastra Holdings Announces Record Single Purchase Order For Over $1M
Via ACCESSWIRE
Adastra Holdings Announces Change of Auditor
Via ACCESSWIRE
Adastra Holdings Reports Third Quarter Results; Demonstrating Gross Revenues of $8.1m
Via ACCESSWIRE
Adastra Holdings Provides Corporate Update Following 2023 Growup Awards Victory as Brand of The Year
Via ACCESSWIRE
Canadian Marijuana Stock Posts 133% YoY Revenue Growth, But Also 124% Higher Net Loss In Q2
Via Benzinga
Topics Cannabis
Exposures Cannabis
Adastra Holdings Reports First Quarter Results; Demonstrating Record Quarterly Gross Revenues of $9.5M
Via ACCESSWIRE
Adastra Holdings Reports FY2022 Results; Demonstrating A Second Year of Record Revenue
Via ACCESSWIRE
Adastra Accelerates Growth; 152% Increase in Shipment Volume
Via ACCESSWIRE
Adastra Labs Clarifies and Retracts Certain Disclosure Related to its Receipt of Health Canada Approval for the Amendment to Include Cocaine Under its Controlled Substances Licence
Via ACCESSWIRE
Adastra Labs Receives Health Canada Approval for the Amendment to Include Cocaine Under its Controlled Substances Dealer’s License
Via ACCESSWIRE
Leadership Update: Adastra Appoints Lachlan McLeod as CFO
Via ACCESSWIRE
Adastra Completes Transaction to Terminate Legacy Supply Agreement, Bringing Phyto Extractions Brand 100% In-House
Via ACCESSWIRE
Adastra Holdings Reports Third Quarter Results; Demonstrating Third Consecutive Quarter of Record Revenue
Via ACCESSWIRE
Adastra Receives Controlled Substances Dealer's License
Via ACCESSWIRE
Adastra Holdings Reports Record Second Quarter Results; Momentum Accelerating in Second Half of the Year
Via ACCESSWIRE
The Power Play by The Market Herald Releases New Interviews With Silver Bullet Mines, Northstar Gold, and Adastra Holdings
From The Market Herald
Via AccessWire
The Power Play by The Market Herald Releases New Interviews With Algernon Pharmaceuticals, Adastra Holdings and C3 Metals
From The Market Herald
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.